Novartis Gets FCA Kickback Suit Pared Down

Law360, Washington (June 11, 2014, 2:50 PM EDT) -- A New York federal judge on Tuesday pared down a whistleblower False Claims Act lawsuit against Novartis Pharmaceuticals Corp. and several specialty pharmacies over an alleged kickback scheme to push Novartis drugs, saying several of the allegations were "vague and unhelpful."

U.S. District Judge Colleen McMahon tossed out relator David M. Kester's claims that Novartis, Accredo Health Group Inc., Curascript Inc. and CVS Caremark Corp. participated in a scheme to push Novartis' leukemia drugs Gleevec and Tasigna and as well as the cystic fibrosis drug Tobi...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.